Arcturus Therapeutics Holdings ARCT Insider Ownership

NASDAQ ARCT
$11.16 +0.19 (+1.68%)
As of: Oct 21, 2026 · 10:58 AM EDT

Insider Holdings by Owner

2.22Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
7.89%
■0% pp QoQ
Shares Held by Insiders
2.24Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
28.42Mn
28,423,000 shares
Direct Holdings
2.22Mn
Indirect: 24.94K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
10
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

In the last 12 months, insiders at Arcturus Therapeutics Holdings neither bought nor sold shares on the open market.

Form 4 Holdings

Insiders Holding ARCT

Insiders 10
Shares held 2.22Mn
Of outstanding 7.81%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Joseph E Payne President And Ceo 1,480,097 0 1,480,097 66.7% 28 Nov, 2022
2 Pad Chivukula Chief Scientific Officer Coo 435,334 0 435,334 19.6% 16 Oct, 2024
3 Andy Sassine Chief Financial Officer 221,764 0 221,764 10.0% 20 Aug, 2025
4 Peter C Farrell Director 55,741 0 55,741 2.5% 18 Jun, 2024
5 James F Barlow Director 13,131 0 13,131 0.6% 18 Jun, 2024
6 Magda Marquet Director 3,131 0 3,131 0.1% 18 Jun, 2024
7 Edward W Holmes Director 3,131 0 3,131 0.1% 18 Jun, 2024
8 John Markels Director 3,131 0 3,131 0.1% 18 Jun, 2024
9 Jing L. Marantz Director 3,131 0 3,131 0.1% 18 Jun, 2024
10 Keith C Kummerfeld Officer 950 0 950 0.0% 18 Jul, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

178 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
05 Jun, 2026 John Markels Director Acquired A 15,000 $0.00 $0 15,000 Direct
05 Jun, 2026 Peter C Farrell Director Acquired A 15,000 $0.00 $0 15,000 Direct
05 Jun, 2026 Jing L. Marantz Director Acquired A 15,000 $0.00 $0 15,000 Direct
05 Jun, 2026 Edward W Holmes Director Acquired A 15,000 $0.00 $0 15,000 Direct
05 Jun, 2026 Magda Marquet Director Acquired A 15,000 $0.00 $0 15,000 Direct
05 Jun, 2026 Moncef Slaoui Director Acquired A 15,000 $0.00 $0 15,000 Direct
05 Jun, 2026 James F Barlow Director Acquired A 15,000 $0.00 $0 15,000 Direct
01 May, 2026 Dennis Mulroy Chief Financial Officer Acquired A 100,000 $0.00 $0 100,000 Direct
17 Dec, 2025 Pad Chivukula Chief Scientific Officer Coo Acquired A 54,000 $0.00 $0 54,000 Direct
17 Dec, 2025 Joseph E Payne President And Ceo Acquired A 175,000 $0.00 $0 175,000 Direct
17 Dec, 2025 Joseph Roberts Controller Acquired A 10,000 $0.00 $0 10,000 Direct
17 Dec, 2025 Lance Kurata Chief Legal Officer Acquired A 54,000 $0.00 $0 54,000 Direct
15 Aug, 2025 Andy Sassine Chief Financial Officer Acquired P 1,238 $16.56 $20.50K 221,764 Direct
15 Aug, 2025 Andy Sassine Chief Financial Officer Disposed P 1,238 $16.56 $20.50K 221,764 Direct
09 Jun, 2025 Magda Marquet Director Acquired A 15,000 $0.00 $0 15,000 Direct
09 Jun, 2025 Peter C Farrell Director Acquired A 15,000 $0.00 $0 15,000 Direct
09 Jun, 2025 Jing L. Marantz Director Acquired A 15,000 $0.00 $0 15,000 Direct
09 Jun, 2025 Edward W Holmes Director Acquired A 15,000 $0.00 $0 15,000 Direct
09 Jun, 2025 Moncef Slaoui Director Acquired A 15,000 $0.00 $0 15,000 Direct
09 Jun, 2025 James F Barlow Director Acquired A 15,000 $0.00 $0 15,000 Direct